{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:25:55Z","timestamp":1794327955007,"version":"4.9.0"},"reference-count":32,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11,10]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Severe thalassemia (ST) is a life-threatening condition common in many low- and middle-income countries. Although bone marrow transplantation (BMT) offers a curative option, its accessibility remains limited because of cost and complexity. This study describes a simplified approach to BMT for hemoglobinopathies that is based on relatively common and inexpensive medicines. This study included 176 pediatric patients with transfusion-dependent thalassemia who received a matched sibling BMT between February 2022 and November 2025 across several centers in Asia and the Middle East. A simplified and low-cost transplant protocol was used, using drugs that are widely available and are listed in the World Health Organization Model List of Essential Medicines. The regimen included fludarabine, dexamethasone, busulfan, and cyclophosphamide. granulocyte colony-stimulating factor\u2013primed bone marrow was used as the graft source, and graft-versus-host disease (GVHD) prophylaxis included cyclosporine and methotrexate. Rejection, mixed-chimerism rates, transplant-related mortality, and GVHD-free, overall survival, and disease-free survival composite outcomes were analyzed. Engraftment was obtained in 97.3% of patients. Thalassemia-free survival was 93.4%, and overall survival was 96%, at a median follow-up of 11.3 months. Rates of moderate to severe acute GVHD were low (3.9%) for a GVHD-free and thalassemia-free composite actuarial outcome of 93.4%. Cytomegalovirus (CMV) reactivation was observed in 19.2% of patients and 1 (0.6%) patient progressed to CMV disease. The approach was equally effective in experienced and newly established transplant centers. A simple, safe, and cost-conscious transplant approach using widely available medicines can achieve excellent outcomes for children with ST in low-resource settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025019083","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T02:04:09Z","timestamp":1784340249000},"page":"7243-7250","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Optimizing outcomes and accessibility of matched sibling donor transplant for transfusion-dependent thalassemia in LMICs"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4836-1470","authenticated-orcid":false,"given":"Mohana","family":"Reddy","sequence":"first","affiliation":[{"name":"1Sankalp India Foundation, Bangalore, India"},{"name":"2Bhagwan Mahaweer Jain Hospital-Sankalp Centre for Pediatric Hematology Oncology and BMT, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5171-1645","authenticated-orcid":false,"given":"Tejashree","family":"Sridhar","sequence":"additional","affiliation":[{"name":"1Sankalp India Foundation, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidhi","family":"Mayur","sequence":"additional","affiliation":[{"name":"1Sankalp India Foundation, Bangalore, India"},{"name":"2Bhagwan Mahaweer Jain Hospital-Sankalp Centre for Pediatric Hematology Oncology and BMT, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetha T.","family":"Lathe","sequence":"additional","affiliation":[{"name":"1Sankalp India Foundation, Bangalore, India"},{"name":"2Bhagwan Mahaweer Jain Hospital-Sankalp Centre for Pediatric Hematology Oncology and BMT, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Trivedi","sequence":"additional","affiliation":[{"name":"1Sankalp India Foundation, Bangalore, India"},{"name":"3Sankalp-Health1 Centre for Paediatric Hematology Oncology and Blood and Marrow Transplant, Ahmedabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8211-1596","authenticated-orcid":false,"given":"Vaibhav","family":"Shah","sequence":"additional","affiliation":[{"name":"1Sankalp India Foundation, Bangalore, India"},{"name":"3Sankalp-Health1 Centre for Paediatric Hematology Oncology and Blood and Marrow Transplant, Ahmedabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Dhanya","sequence":"additional","affiliation":[{"name":"1Sankalp India Foundation, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalith","family":"Parmar","sequence":"additional","affiliation":[{"name":"1Sankalp India Foundation, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7440-2502","authenticated-orcid":false,"given":"Priya","family":"Marwah","sequence":"additional","affiliation":[{"name":"4Mahatma Gandhi Medical College and Hospital and South East Asian Institute of Technology, Jaipur, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder","family":"Shahad Marzook","sequence":"additional","affiliation":[{"name":"5Al-Mujtaba Hospital, Karbala, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliya","family":"Batool","sequence":"additional","affiliation":[{"name":"6Dr Akbar Niazi Teaching Hospital, Islamabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2525-4368","authenticated-orcid":false,"given":"Kim","family":"Hoa Nguyen","sequence":"additional","affiliation":[{"name":"7Hue Central Hospital, Hue, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Begali","family":"Saytov","sequence":"additional","affiliation":[{"name":"8National Children\u2019s Medical Center, Tashkent, Uzbekistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Sedai","sequence":"additional","affiliation":[{"name":"1Sankalp India Foundation, Bangalore, India"},{"name":"9Jagriti InnoHealth Platforms Pvt Ltd, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumari","family":"Ankita","sequence":"additional","affiliation":[{"name":"1Sankalp India Foundation, Bangalore, India"},{"name":"9Jagriti InnoHealth Platforms Pvt Ltd, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4864-6479","authenticated-orcid":false,"given":"Rajat Kumar","family":"Agarwal","sequence":"additional","affiliation":[{"name":"1Sankalp India Foundation, Bangalore, India"},{"name":"9Jagriti InnoHealth Platforms Pvt Ltd, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Faulkner","sequence":"additional","affiliation":[{"name":"1Sankalp India Foundation, Bangalore, India"},{"name":"10Cure2Children Foundation, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,10,29]]},"reference":[{"issue":"6","key":"2026111011015138700_bib1","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2471\/BLT.06.036673","article-title":"Global epidemiology of haemoglobin disorders and derived service indicators","volume":"86","author":"Modell","year":"2008","journal-title":"Bull World Health Organ"},{"issue":"7","key":"2026111011015138700_bib2","first-page":"1448","article-title":"Life expectancy and risk factors for early death in patients with severe thalassemia syndromes in South India","volume":"4","author":"Dhanya","year":"2020","journal-title":"Blood Adv"},{"issue":"5","key":"2026111011015138700_bib3","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/bjh.17091","article-title":"Co-morbidities and mortality associated with transfusion-dependent beta-thalassaemia in patients in England: a 10-year retrospective cohort analysis","volume":"191","author":"Jobanputra","year":"2020","journal-title":"Br J Haematol"},{"issue":"13","key":"2026111011015138700_bib4","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1182\/bloodadvances.2016004119","article-title":"ATG vs. thiotepa with busulfan and cyclophosphamide in matched-related bone marrow transplantation for thalassemia","volume":"1","author":"Faulkner","year":"2017","journal-title":"Blood Adv"},{"issue":"13","key":"2026111011015138700_bib5","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1182\/blood-2013-05-502658","article-title":"Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia","volume":"122","author":"La Nasa","year":"2013","journal-title":"Blood"},{"issue":"1","key":"2026111011015138700_bib6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/1472-6963-10-209","article-title":"A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand","volume":"10","author":"Leelahavarong","year":"2010","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"2026111011015138700_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.phoj.2017.12.002","article-title":"Low-cost matched sibling bone marrow transplant for standard-risk thalassemia in a limited-resource setting","volume":"2","author":"Ramprakash","year":"2017","journal-title":"Pediatr Hematol Oncol J"},{"issue":"11","key":"2026111011015138700_bib8","doi-asserted-by":"crossref","first-page":"926.e1","DOI":"10.1016\/j.jtct.2025.07.011","article-title":"A ten-year follow-up study of children with thalassemia major post transplantation using treosulfan, thiotepa, and fludarabine-based conditioning regimen and its impact on growth and puberty","volume":"31","author":"Ganesan","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"16","key":"2026111011015138700_bib9","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.2010.491","article-title":"Hematopoietic stem cell transplantation: a global perspective","volume":"303","author":"Gratwohl","year":"2010","journal-title":"JAMA"},{"key":"2026111011015138700_bib10","unstructured":"World Health Organisation\n          . WHO Model Lists of Essential Medicines. Accessed 25 July 2019. http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/en\/."},{"issue":"9","key":"2026111011015138700_bib11","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.bbmt.2017.05.030","article-title":"The case for high resolution extended 6-loci HLA typing for identifying related donors in the Indian subcontinent","volume":"23","author":"Agarwal","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"2026111011015138700_bib12","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1182\/blood.2023022460","article-title":"Pretransfusion hemoglobin level and mortality in adults with transfusion-dependent \u03b2-thalassemia","volume":"143","author":"Musallam","year":"2024","journal-title":"Blood"},{"issue":"5","key":"2026111011015138700_bib13","doi-asserted-by":"crossref","first-page":"319.e1","DOI":"10.1016\/j.jtct.2025.01.890","article-title":"Granulocyte colony-stimulating factor\u2013primed bone marrow transplantation experience in 350 matched sibling donor grafts for severe thalassemia","volume":"31","author":"Agarwal","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"2026111011015138700_bib14","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/amiajnl-2013-002594","article-title":"A prospective international cooperative information technology platform built using open-source tools for improving the access to and safety of bone marrow transplantation in low- and middle-income countries","volume":"21","author":"Agarwal","year":"2014","journal-title":"J Am Med Inform Assoc"},{"issue":"7","key":"2026111011015138700_bib15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199002153220701","article-title":"Bone marrow transplantation in patients with thalassemia","volume":"322","author":"Lucarelli","year":"1990","journal-title":"N Engl J Med"},{"issue":"4","key":"2026111011015138700_bib16","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2141.2008.07385.x","article-title":"Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major","volume":"143","author":"Bernardo","year":"2008","journal-title":"Br J Haematol"},{"issue":"5","key":"2026111011015138700_bib17","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1182\/blood-2010-09-306829","article-title":"HLA-matched sibling bone marrow transplantation for \u03b2-thalassemia major","volume":"117","author":"Sabloff","year":"2011","journal-title":"Blood"},{"key":"2026111011015138700_bib18","unstructured":"US Food and Drug Administration\n          . Fludarabine Phosphate Injection. Prescription Information. 2010. Accessed 1 August 2026. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/022137s003lbl.pdf."},{"issue":"17","key":"2026111011015138700_bib19","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/bloodadvances.2019000291","article-title":"Related and unrelated donor transplantation for \u03b2-thalassemia major: results of an international survey","volume":"3","author":"Li","year":"2019","journal-title":"Blood Adv"},{"issue":"9","key":"2026111011015138700_bib20","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/bmt.2015.80","article-title":"G-CSF-primed bone marrow as a source of stem cells for allografting: revisiting the concept","volume":"50","author":"Deotare","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"2026111011015138700_bib21","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/s41409-018-0208-3","article-title":"Peripheral hematopoietic stem cell mobilization utilizing growth factors in donors with sickle cell trait is safe and effective","volume":"53","author":"Damlaj","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2026111011015138700_bib22","doi-asserted-by":"crossref","first-page":"217.e1","DOI":"10.1016\/j.jtct.2025.10.007","article-title":"Acute toxicities of bone marrow donation in unrelated donors with sickle cell trait: a CIBMTR analysis","volume":"32","author":"Farhadfar","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"4","key":"2026111011015138700_bib23","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/bjh.70049","article-title":"The importance of systemic inflammatory response measurements as pretransplant risk factors for outcome after allogeneic haematopoietic cell transplantation","volume":"207","author":"Bertz","year":"2025","journal-title":"Br J Haematol"},{"issue":"11","key":"2026111011015138700_bib24","doi-asserted-by":"crossref","first-page":"932.e1","DOI":"10.1016\/j.jtct.2025.07.020","article-title":"Risk-stratified pre-transplant immunosuppressive strategy improves outcomes of unrelated cord blood transplantation in pediatric \u03b2-thalassemia major","volume":"31","author":"Wu","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"5","key":"2026111011015138700_bib25","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1470-2045(16)00086-3","article-title":"Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort","volume":"17","author":"Chow","year":"2016","journal-title":"Lancet Oncol"},{"issue":"suppl 1","key":"2026111011015138700_bib26","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1038\/bmt.2008.124","article-title":"Stem cell transplantation in India","volume":"42","author":"Chandy","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2026111011015138700_bib27","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/bmt.2014.299","article-title":"Hematopoietic SCT in Iranian children 1991-2012","volume":"50","author":"Hamidieh","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"2026111011015138700_bib28","doi-asserted-by":"crossref","first-page":"e2014046","DOI":"10.4084\/mjhid.2014.046","article-title":"Cost of hematopoietic stem cell transplantation in India","volume":"6","author":"Sharma","year":"2014","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"5","key":"2026111011015138700_bib29","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41409-018-0333-z","article-title":"Challenges in managing graft-versus-host disease in developing countries: a perspective","volume":"54","author":"Saleem","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"2026111011015138700_bib30","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/s41409-020-0899-0","article-title":"Financial impact of post-transplant complications among children undergoing allogeneic hematopoietic cell transplantation","volume":"55","author":"Ricci","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"2026111011015138700_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1182\/hematology.2023000513","article-title":"When should gene therapy be considered for transfusion-dependent \u03b2-thalassemia patients?","volume":"2023","author":"Mensah","year":"2023","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2026111011015138700_bib32","first-page":"26330040261433028","article-title":"Current therapeutic landscape of \u03b2-thalassemia: focus on gene therapy","volume":"7","author":"Cheng","year":"2026","journal-title":"Ther Adv Rare Dis"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/21\/7243\/2597392\/blooda_adv-2025-019083-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/21\/7243\/2597392\/blooda_adv-2025-019083-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:02:04Z","timestamp":1794326524000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/21\/7243\/569760\/Optimizing-outcomes-and-accessibility-of-matched"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,29]]},"references-count":32,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026,11,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025019083","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11,10]]},"published":{"date-parts":[[2026,10,29]]}}}